Viral Infection Linked to ALS: New Mouse Model Offers Hope for Treatment
A new study is offering a potential breakthrough in understanding the development of debilitating motor neuron diseases, including amyotrophic lateral sclerosis (ALS). Researchers have identified a specific mouse strain that exhibits responses to viral infection mirroring those observed in humans with ALS.
Uncovering a Potential Link
The research team focused on the CC023 mouse strain, noting its unique reaction to viral exposure. This strain’s response is remarkably similar to the progression of ALS in humans, according to the study. “This is exciting because this is the first animal model that affirms the long-standing theory that a virus can trigger permanent neurological damage or disease—like ALS—long after the infection itself occurred,” explains Candice Brinkmeyer-Langford, a neurogenerative disease expert with the Texas A&M University School of Public Health.
How the Study Was Conducted
The study, published in the Journal of Neuropathology & Experimental Neurology, involved infecting five genetically diverse mouse strains with Theiler’s murine encephalomyelitis virus (TMEV). Researchers then meticulously tracked the effects of the virus across acute, subacute and chronic phases of infection. They used five key methods to assess the mice: comparing spinal cord inflammation, analysing inflammation levels between strains, linking inflammation to physical symptoms, measuring virus amounts, and determining if virus levels correlated with spinal cord inflammation.
Key Findings from the Research
The research yielded four significant findings. First, nerve damage was observed in the lumbar spine of all mouse strains within the first two weeks of infection, with some showing illness as early as four days post-infection. Second, the CC023 mice experienced permanent muscle wasting even after the virus was eliminated from their spinal cords. Third, the CC023 mice displayed physical symptoms and lesions closely resembling those seen in human ALS patients. Finally, while the mice’s immune systems initially mounted a strong defence against the virus, this activity subsided once the virus was cleared.
the initial viral infection triggered an immune response, lesions, and early signs of illness. Although the virus eventually cleared, the lesions and symptoms persisted, particularly in the CC023 strain, mirroring the characteristics of ALS.
What Could Happen Next
The CC023 mouse strain could prove invaluable for identifying early biomarkers of ALS following infection. Researchers may be able to use this model to test potential treatments, particularly for sporadic ALS. Further research could explore the genetic factors that make the CC023 strain uniquely susceptible to long-term damage. It is also possible that this research could lead to a better understanding of the role of the immune system in the progression of ALS.
Frequently Asked Questions
What did researchers discover about nerve damage?
Within the first two weeks of infection, all mouse strains showed nerve damage in the lumbar spine. Some strains showed signs of illness as early as four days after infection.
What happened with muscle loss in the CC023 mice?
Over the long-term phase of the illness, the virus was eliminated from the spinal cord of the CC023 mice, but they experienced permanent muscle wasting.
What role did the immune system play in this study?
The immune cells of the mice were very active early on to fight the virus, but this activity stopped once the virus was cleared.
Considering the potential link between viral infections and the development of ALS, how might this research influence preventative health strategies in the future?